Scientist, Toxicology (Watertown, MA - Onsite)

• Oversee preclinical toxicology studies at external contract research organizations (CRO), including:
  • Facilitate study initiation by executing appropriate processes for contract implementation, test article procurement, protocol development, and timeline commitments.
  • Monitor studies for appropriate conduct, accuracy and timely completion; audit raw data for accuracy; and review draft reports for completion.
  • Anticipate study problems and opportunities and raise issues with suggested resolutions to supervisor.
  • Ensure appropriate project management and oversight with multiple CROs.
• Evaluate individual and programmatic study data (anatomic pathology, clinical pathology, in-life parameters, etc.) as to the potential toxicity of experimental compounds in different animal species and prepare verbal and written summaries for internal discussions.
• Work with the Toxicology team to develop optimal strategies to address specific safety issues and partner with project teams to select and advance Development compounds.
• Serve as a key resource, providing scientific knowledge and expertise to cross-functional project teams.
• Contribute to various regulatory documents (e.g., Pre-IND, IND, IB, CTA, PIP/PSP, etc.) and ensure regulatory compliance (US FDA Good Laboratory Practice-21 CFR Part 58).
• Build strong collaborative relationships with research and development teams to meet project, departmental, and company goals.

• DVM/PhD (strongly preferred), DVM or PhD in Toxicology, Pathology, or related health science field
• Solid foundation in animal and/or biomedical sciences, including toxicology, pathology, and physiology with proficient knowledge of developmental and reproductive biology
• Excellent written and oral communication skills
• Strong commitment to quality and accountability
• Data-driven decision-making
• Strong organizational and project management skills
• Effective problem-solving skills and judgement
• Able to work in a highly collaborative environment

Please complete the application below and include the following attachments:

• Cover Letter
• CV / Resume
• Research Summary (if applicable)

Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta’s research and development programs are currently focused on respiratory syncytial virus (RSV) and chronic spontaneous urticaria (CSU) and the company has previously advanced clinical-stage compounds for SARS-CoV-2 (COVID-19) and chronic hepatitis B virus (HBV) infection.

Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET® (U.S.) and MAVIRET® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta’s royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta’s operations. Please visit www.enanta.com for more information.

Enanta Pharmaceuticals is an equal opportunity employer (EOE) with a commitment to diversity. All individuals, regardless of personal characteristics, are encouraged to apply. All qualified applicants will receive consideration for employment without regard to race, color, national origin, age, religious creed, gender, gender identity, sexual orientation, physical or mental disability, protected veteran status, or any other class protected by law.

This is a full time position